Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q1 2024 Contract Research Organizations Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q1 2024 Contract Research Organizations Update

As the pharmaceutical and biotechnology industries continue to expand pipelines, demand for outsourced pharma and CRO services remains as strong as ever to oversee and manage a continuously growing number of clinical trials globally. Rising complexities within these clinical trials from an operational and regulatory perspective are driving CROs to leverage mergers and acquisitions to enhance their capabilities and offer an efficient product to clients.

In recent quarters, CROs are leveraging inorganic strategies to expand services offerings, build geographic reach, and achieve greater efficiency through technological advancements / enhancements to improve biometrics capabilities and accelerate clinical trial timelines.

To print and download the full Contract Research Organizations Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/04/Q1-2024-CRO-Newsletter.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]